Despite the fact that noncancerous cells can also be killed by TRAIL under certain circumstances, the development of TRAIL as an anti-cancer agent has continued and the vast majority of work with TRAIL has focused on its tumoricidal activity. Here, TNFSF10 is linked to cancer.